COVID-19 Neurological Effects as a Result of Autoimmunity in the PNS
Support for indirect over direct causes of neurological symptoms:
- Cerebralspinal fluid (CSF) samples in some CoV-2 patients have shown the presence of SARS-CoV-2 antibodies (anti-S1 IgM) and increased multiple cytokines, suggesting a possible CoV-2 direct infection of the CNS (Benameur et. al). However, this coupled with low levels of CSF and plasma viral RNA in patients, suggests that the neurological symptoms present may be a result of autoimmune responses, rather than direct infection.
Support for autoimmunity:
- the anti-neuronal and anti-glial autoantibodies presence in CSF and serum lends support of a causal relationship between autoimmunity and neurological clinical symptoms (Franke et. al)
- transcriptomic data from COVID-19 patients, control samples, and mice studies, reveal evidence of virus-driven cell lysis (Ray et. al)
0
1
References
Early Release-Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020
High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms
A pharmacological interactome between COVID-19 patient samples and human sensory neurons reveals potential drivers of neurogenic pulmonary dysfunction
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Neuro-Immune Cellular Interactions from SARS-CoV-2 Infection.
COVID-19 Neurological Effects as a Result of Autoimmunity in the PNS
Mechanisms of CoV infections on the nervous system damage
Neurological symptoms Presented in COVID-19 Patients
COVID-19 Neurological Effects as a Result of Autoimmunity in the PNS